Studies show that combining Clomid and Metformin boosts pregnancy rates compared to Clomid alone. A meta-analysis published in the journal Human Reproduction Update reported a significant increase in live birth rates, ranging from 10% to 20% higher, depending on the study and patient population. However, these success rates aren’t universal.
Who Benefits Most?
Successful treatment hinges on careful patient selection. Women with polycystic ovary syndrome (PCOS) often see the greatest benefit. Specifically, women with PCOS exhibiting insulin resistance respond particularly well to the addition of Metformin, which improves insulin sensitivity and ovulation. Other candidates include women with unexplained infertility or those who haven’t responded adequately to Clomid alone. Conversely, women with low ovarian reserve or severe tubal damage may see minimal improvement from the combined approach.
Factors Affecting Outcomes
Beyond PCOS, several factors influence treatment success. Body Mass Index (BMI) plays a role; women with higher BMIs might require more aggressive management. Age is another key factor; younger women generally have higher success rates. Duration of infertility and prior treatment history also inform the prognosis. Finally, individual responses to medication vary considerably, highlighting the need for close monitoring and adjustments throughout treatment.
